Tag Archives: NASDAQ:SPPI

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) and Spectrum Pharmaceuticals (NASDAQ:SPPI) Inks Deal to Create Captisol

Posted on March 14, 2013 by Thomas Vedder

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) inked a global licensing and supply agreement with Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) to create Ligand’s Captisol-enabled melphalan for use as an element of multiple myeloma transplant programs, an agreement possibly worth at over $53 million.

Ligand …

Posted in Latest Headlines | Tagged LGND, Ligand Pharmaceuticals, NASDAQ:LGND, NASDAQ:SPPI, Spectrum Pharmaceuticals, SPPI | Comments Off

Healthcare Sector Overview: Sucampo Pharmaceuticals (NASDAQ:SCMP), BG Medicine (NASDAQ:BGMD) – SCMP, BGMD, DCTH, FOLD, SNSS, SPPI

Posted on March 14, 2013 by Thomas Vedder

Healthcare sector reacted positively on Wednesday’s trading session and sector moved up -0.12%. If we look at the key movers of the sector so Amicus Therapeutics, Inc (NASDAQ:FOLD) and Sunesis Pharmaceuticals, Inc (NASDAQ:SNSS) were major percentage gainers while key percentage …

Posted in Healthcare, Latest Headlines | Tagged Amicus Therapeutics, BG Medicine, BGMD, DCTH, Delcath Systems, FOLD, NASDAQ:BGMD, NASDAQ:DCTH, NASDAQ:FOLD, NASDAQ:SCMP, Nasdaq:SNSS, NASDAQ:SPPI, SCMP, SNSS, spectrum, SPPI, Sucampo Pharmaceuticals, Sunesis | Comments Off

Review of Key Percentage Decliners: Velti (NASDAQ:VELT), Spectrum Pharmaceuticals (NASDAQ:SPPI)

Posted on March 13, 2013 by Thomas Vedder

Shares of Velti Plc (NASDAQ:VELT) plunged almost 30% to $2.18 in premarket trading session on Wednesday. Shares of the company tumbled as it swung to loss in fiscal fourth-quarter.

The mobile marketing company announced heavy charges and operating expenses directed …

Posted in Latest Headlines | Tagged NASDAQ:SPPI, NASDAQ:VELT, Spectrum Pharmaceuticals, SPPI, VELT, Velti | Comments Off

Volume Gainers Watch List: XOMA (NASDAQ:XOMA), Spectrum Pharmaceuticals (NASDAQ:SPPI) – XOMA, SPPI, AGN, BIOS, DVAX, XNPT

Posted on March 13, 2013 by Thomas Vedder

Tuesday’s trading session data confirmed that healthcare sector reacted positively and the major percentage gainer in sectors. BioScrip Inc (NASDAQ:BIOS) and Dynavax Technologies Corporation (NASDAQ:DVAX) were major percentage gainer in this sector while key percentage decliner was XenoPort, Inc (NASDAQ:XNPT).…

Posted in Latest Headlines, Services | Tagged AGN, Allergan, BIOS, BioScrip, DVAX, Dynavax Technologies, NASDAQ:BIOS, NASDAQ:DVAX, NASDAQ:SPPI, NASDAQ:XNPT, NASDAQ:XOMA, NYSE:AGN, Spectrum Pharmaceuticals, SPPI, XenoPort, XNPT, Xoma | Comments Off

AEterna Zentaris (NASDAQ:AEZS) Stock Hikes after FDA Deal – AEZS, MRK, SPPI, NVS

Posted on December 29, 2012 by Geoff Noir

AEterna Zentaris Inc’s (USA) (NASDAQ:AEZS) stock moved up almost 20% on Friday after the Canadian drug manufacturer reported that it has agreed with United States rules on the design of a late-stage inquiry for its endometrial cancer treatment.

The Canadian …

Posted in Healthcare, Latest Headlines | Tagged AEterna Zentaris, AEZS, Merck, MRK, NASDAQ:AEZS, NASDAQ:SPPI, Novartis AG, NVS, NYSE:MRK, NYSE:NVS, Spectrum Pharmaceuticals, SPPI | Comments Off

Jazz Pharma (NASDAQ:JAZZ) Climbs Over 14% on $700M Agreement- JAZZ , DNDN, QCOR, HGSI, SPPI, KERX, VVUS

Posted on April 30, 2012 by Geoff Noir

Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) moved up on Friday following the Irish drug firm decided to purchase cancer drug maker EUSA Pharma for as much as $700 million.

Jazz reported that it settled to purchase EUSA for $650 million …

Posted in Latest Headlines | Tagged Dendreon, DNDN, HGSI, Human Genome Sciences, JAZZ, Jazz Pharmaceuticals, KERX, Keryx, NASDAQ:DNDN, NASDAQ:HGSI, NASDAQ:JAZZ, NASDAQ:KERX, NASDAQ:QCOR, NASDAQ:SPPI, NASDAQ:VVUS, QCOR, Questcor, Spectrum Pharmaceuticals, SPPI, Vivus, VVUS | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.